ANN ARBOR, Mich. -- A test used to detect prostate cancer can also help doctors know when treatment is working. A man’s prostate specific antigen, or PSA, level after seven months of hormone therapy for advanced prostate cancer predicted how long he would survive, according to a new multicenter study conducted by the Southwest Oncology Group and led by researchers at the University of Michigan Comprehensive Cancer Center.
